Ind-Swift Laboratories has informed that in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (the SEBI Regulations), Code of Practices and Procedures for Prevention of Insider Trading and Code of Conduct & Fair Disclosure of Unpublished Price Sensitive Information (Company Code) and SEBI Circular No. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020, the details of violation of the SEBI Regulations and Company Code by the Designated Person along with the action taken by the Company thereon is enclosed as ‘Annexure A’.
The above information is a part of company’s filings submitted to BSE.
